ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 54 filers reported holding ALPINE IMMUNE SCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,190,000 | +16.7% | 111,501 | -1.6% | 0.32% | +48.4% |
Q2 2021 | $1,020,000 | -15.1% | 113,302 | 0.0% | 0.21% | -25.3% |
Q1 2021 | $1,201,000 | -15.8% | 113,302 | +0.1% | 0.28% | -32.8% |
Q4 2020 | $1,426,000 | +9.4% | 113,202 | -23.6% | 0.42% | 0.0% |
Q3 2020 | $1,303,000 | – | 148,260 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |